Portfolio

Company Announcements

Director/PDMR Shareholding

Related Companies

By LSE RNS

RNS Number : 4785G
Arix Bioscience Plc
30 May 2017
 

Director/PDMR Shareholding

 

 

LONDON, 30 May 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, announces that awards of shares have been made to several key members of its leadership team under the Company's Long Term Incentive Plan ("LTIP").

 

Awards of nil cost options have been made to Joseph Anderson, Chief Executive Officer, and James Rawlingson, Chief Financial Officer; a conditional share award has been made to Jonathan Peacock, Chairman.

 

These will be exercisable in three years' time, subject to the rules of the LTIP and to performance conditions relating to the growth of the Company's share price.  Details of the maximum awards possible are set out below in the PDMR Dealing Notification Forms.

 

 

PDMR Dealing Notifications

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joseph Anderson

2

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

 Award of nil-cost options under the Arix Bioscience plc Long-term Incentive Plan ("LTIP") 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

569,619

d)

Aggregated information

Aggregated price

Aggregated volume

N/A

N/A

e)

Date of the transaction

 26 May 2017 

f)

Place of the transaction

Outside of a trading venue

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonathan Peacock

2

Reason for the notification

a)

Position / status

Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Conditional share award under the Arix Bioscience plc Long-term Incentive Plan ("LTIP") 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

379,746

d)

Aggregated information

Aggregated price

Aggregated volume

N/A

N/A

e)

Date of the transaction

 26 May 2017 

f)

Place of the transaction

Outside of a trading venue

 

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Hedley Rawlingson

2

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

 Award of nil-cost options under the Arix Bioscience plc Long-term Incentive Plan ("LTIP") 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

205,062

d)

Aggregated information

Aggregated price

Aggregated volume

N/A

N/A

e)

Date of the transaction

 26 May 2017 

f)

Place of the transaction

Outside of a trading venue

 

For further information:

 

James Rawlingson                           Chief Financial Officer                +44 (0)207 290 1050

 

 

 - Ends -

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKLLLDEFFBBB

Top of Page